NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM).

NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM). Other Scholarly Work

Gondi, Vinai; Deshmukh, Snehal; Brown, Paul D; Wefel, Jeffrey Scott; Tome, Wolfgang; Armstrong, Terri; Bruner, Deborah; Bovi, Joseph A; Robinson, Cliff Grant; Khuntia, Deepak; Grosshans, David R; Konski, Andre A; Roberge, David; Kundapur, Vijayananda; Devisetty, Kiran; Shah, Sunjay A; Usuki, Kenneth; Anderson, Bethany Marie; Mehta, Minesh P; Kachnic, Lisa A